Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Iambic Therapeutics, Inc. IAM

Full chart Compare
Set alert

Price alert · IAM

All alert types
13.38 USD +3.21 (+31.56%)

At closeNov 10, 2026, 5:05 AM EST

14.81 +1.43 +10.69%

Pre-market · Nov 10, 5:05 AM ET

9.90 Day range 13.47
9.60 52-week range 25.00
YTD
-29.24%
1 year
-29.24%

Revenue & Expenses

Other Income → Expenses: $5.12MExpenses → Selling, General & Admin: $14.25MExpenses → Research & Development: $77.53MExpenses → Interest Expense: $17.00KExpenses → Income Tax: $45.00KGross Profit → Expenses: $9.43MRevenue → Gross Profit: $9.43MNet Loss → Expenses: $77.30MOther Income$5.12MGross Profit$9.43MNet Loss$77.30MExpenses$91.84MSelling, General & Admin$14.25MResearch & Development$77.53MInterest Expense$17.00KIncome Tax$45.00KRevenue$9.43M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
IAM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
9.43M1.19M
9.43M1.19M
-82.35M-53.88M
-77.30M-47.88M
-3.57-2.23

Balance sheet

Full balance sheet How to read it
IAM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
180.54M141.58M
195.02M155.75M
40.25M25.34M
5.46M6.21M
-186.56M-112.25M

Cash flow

Full cash flow How to read it
IAM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-58.82M-33.56M
-1.28M-707.00K
99.06M64.99M
-1.28M-707.00K
38.96M30.73M